195 related articles for article (PubMed ID: 32905914)
21. Common and Specific Functional Activity Features in Schizophrenia, Major Depressive Disorder, and Bipolar Disorder.
Yang Y; Liu S; Jiang X; Yu H; Ding S; Lu Y; Li W; Zhang H; Liu B; Cui Y; Fan L; Jiang T; Lv L
Front Psychiatry; 2019; 10():52. PubMed ID: 30837901
[No Abstract] [Full Text] [Related]
22. Machine-learning-based classification between post-traumatic stress disorder and major depressive disorder using P300 features.
Shim M; Jin MJ; Im CH; Lee SH
Neuroimage Clin; 2019; 24():102001. PubMed ID: 31627171
[TBL] [Abstract][Full Text] [Related]
23. A diagnostic model based on bioinformatics and machine learning to differentiate bipolar disorder from schizophrenia and major depressive disorder.
Shen J; Xiao C; Qiao X; Zhu Q; Yan H; Pan J; Feng Y
Schizophrenia (Heidelb); 2024 Feb; 10(1):16. PubMed ID: 38355593
[TBL] [Abstract][Full Text] [Related]
24. Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation.
Bai S; Fang L; Xie J; Bai H; Wang W; Chen JJ
J Inflamm Res; 2021; 14():495-503. PubMed ID: 33654420
[TBL] [Abstract][Full Text] [Related]
25. Altered resting-state cerebral blood flow and functional connectivity of striatum in bipolar disorder and major depressive disorder.
He Z; Sheng W; Lu F; Long Z; Han S; Pang Y; Chen Y; Luo W; Yu Y; Nan X; Cui Q; Chen H
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():177-185. PubMed ID: 30500413
[TBL] [Abstract][Full Text] [Related]
26. Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders.
Preece RL; Han SYS; Bahn S
Expert Rev Proteomics; 2018 Apr; 15(4):325-340. PubMed ID: 29466886
[TBL] [Abstract][Full Text] [Related]
27. Can lncRNAs be indicators for the diagnosis of early onset or acute schizophrenia and distinguish major depressive disorder and generalized anxiety disorder?-A cross validation analysis.
Cui X; Niu W; Kong L; He M; Jiang K; Chen S; Zhong A; Li W; Lu J; Zhang L
Am J Med Genet B Neuropsychiatr Genet; 2017 Jun; 174(4):335-341. PubMed ID: 28371072
[TBL] [Abstract][Full Text] [Related]
28. Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways towards drug discovery.
Fernandes BS; Dai Y; Jia P; Zhao Z
Eur Neuropsychopharmacol; 2022 Aug; 61():43-59. PubMed ID: 35763977
[TBL] [Abstract][Full Text] [Related]
29. Neurobiological Commonalities and Distinctions Among Three Major Psychiatric Diagnostic Categories: A Structural MRI Study.
Chang M; Womer FY; Edmiston EK; Bai C; Zhou Q; Jiang X; Wei S; Wei Y; Ye Y; Huang H; He Y; Xu K; Tang Y; Wang F
Schizophr Bull; 2018 Jan; 44(1):65-74. PubMed ID: 29036668
[TBL] [Abstract][Full Text] [Related]
30. TCF4 and RBFOX1 as peripheral biomarkers for the differential diagnosis and treatment of major depressive disorder.
Xu K; Ren Y; Fan L; Zhao S; Feng J; Zhong Q; Tu D; Wu W; Chen J; Xie P
J Affect Disord; 2024 Jan; 345():252-261. PubMed ID: 37890537
[TBL] [Abstract][Full Text] [Related]
31. Differential neural correlates of autobiographical memory recall in bipolar and unipolar depression.
Young KD; Bodurka J; Drevets WC
Bipolar Disord; 2016 Nov; 18(7):571-582. PubMed ID: 27813234
[TBL] [Abstract][Full Text] [Related]
32. Plasma oxytocin levels in major depressive and bipolar II disorders.
Lien YJ; Chang HH; Tsai HC; Kuang Yang Y; Lu RB; See Chen P
Psychiatry Res; 2017 Dec; 258():402-406. PubMed ID: 28865715
[TBL] [Abstract][Full Text] [Related]
33. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
[TBL] [Abstract][Full Text] [Related]
34. Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
Çakici N; Sutterland AL; Penninx BWJH; Dalm VA; de Haan L; van Beveren NJM
Brain Behav Immun; 2020 Aug; 88():547-558. PubMed ID: 32330592
[TBL] [Abstract][Full Text] [Related]
35. Quantitative separation of the depressive phase of bipolar disorder and major depressive disorder using electrovestibulography.
Lithgow BJ; Moussavi Z; Fitzgerald PB
World J Biol Psychiatry; 2019 Dec; 20(10):799-812. PubMed ID: 30912461
[No Abstract] [Full Text] [Related]
36. State-Dependent Differences in Emotion Regulation Between Unmedicated Bipolar Disorder and Major Depressive Disorder.
Rive MM; Mocking RJ; Koeter MW; van Wingen G; de Wit SJ; van den Heuvel OA; Veltman DJ; Ruhé HG; Schene AH
JAMA Psychiatry; 2015 Jul; 72(7):687-96. PubMed ID: 25945779
[TBL] [Abstract][Full Text] [Related]
37. Regional brain volume reductions in major depressive disorder and bipolar disorder: An analysis by voxel-based morphometry.
Niida R; Yamagata B; Matsuda H; Niida A; Uechi A; Kito S; Mimura M
Int J Geriatr Psychiatry; 2019 Jan; 34(1):186-192. PubMed ID: 30328161
[TBL] [Abstract][Full Text] [Related]
38. Urinary peptidomics identifies potential biomarkers for major depressive disorder.
Wang Y; Chen J; Chen L; Zheng P; Xu HB; Lu J; Zhong J; Lei Y; Zhou C; Ma Q; Li Y; Xie P
Psychiatry Res; 2014 Jun; 217(1-2):25-33. PubMed ID: 24661976
[TBL] [Abstract][Full Text] [Related]
39. A preliminary composite of blood-based biomarkers to distinguish major depressive disorder and bipolar disorder in adolescents and adults.
Huang J; Hou X; Li M; Xue Y; An J; Wen S; Wang Z; Cheng M; Yue J
BMC Psychiatry; 2023 Oct; 23(1):755. PubMed ID: 37845658
[TBL] [Abstract][Full Text] [Related]
40. Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.
Al Shweiki MR; Oeckl P; Steinacker P; Hengerer B; Schönfeldt-Lecuona C; Otto M
Expert Rev Proteomics; 2017 Jun; 14(6):499-514. PubMed ID: 28562112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
